Merck & Co., Inc.
MRK
$104.83
$0.200.19%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.72% | -1.90% | -1.56% | 6.79% | 4.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.72% | -1.90% | -1.56% | 6.79% | 4.35% |
| Cost of Revenue | -3.68% | -7.80% | -1.20% | -2.32% | -8.11% |
| Gross Profit | 5.97% | -0.15% | -1.66% | 9.99% | 8.85% |
| SG&A Expenses | -2.44% | -2.08% | 3.71% | 1.89% | 8.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.81% | 1.59% | 2.56% | -32.72% | 24.44% |
| Operating Income | 61.53% | -7.22% | -7.14% | 916.67% | -28.26% |
| Income Before Tax | 64.91% | -16.77% | 4.11% | 303.81% | -27.22% |
| Income Tax Expenses | 3.12% | 4.77% | -9.41% | 151.95% | 6.78% |
| Earnings from Continuing Operations | 83.07% | -18.92% | 6.67% | 405.38% | -33.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 50.00% | 83.33% | -20.00% | -- | 20.00% |
| Net Income | 83.24% | -18.85% | 6.66% | 405.30% | -33.47% |
| EBIT | 61.53% | -7.22% | -7.14% | 916.67% | -28.26% |
| EBITDA | 47.86% | -6.21% | -4.45% | 2,492.37% | -21.97% |
| EPS Basic | 86.10% | -18.07% | 7.08% | 404.83% | -33.39% |
| Normalized Basic EPS | 56.23% | -6.32% | -6.05% | 620.63% | -24.73% |
| EPS Diluted | 86.98% | -17.76% | 7.49% | 404.83% | -33.33% |
| Normalized Diluted EPS | 56.48% | -6.06% | -5.95% | 620.63% | -24.67% |
| Average Basic Shares Outstanding | -1.54% | -0.95% | -0.39% | 0.16% | -0.12% |
| Average Diluted Shares Outstanding | -1.69% | -1.22% | -0.51% | 0.16% | -0.20% |
| Dividend Per Share | 5.19% | 5.19% | 5.19% | 5.48% | 5.48% |
| Payout Ratio | -0.43% | 0.29% | -0.01% | 1.35% | 0.58% |